| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Aug 24 | MURA Mural Oncology | Ordinary Shares | Buy | Acquire P | No | No | 3.2071 | 10,000 | 32.07 k | 10,000 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 16,913 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 81,065 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 124,168 | 0.00 | 0 |
| 30 May 24 | MURA Mural Oncology | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 3.35 | 8,462 | 28.35 k | 8,462 |
| 19 Jan 24 | CERE Cerevel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 81,065 | 0.00 | 81,065 |
